Knowledge Center
Article / Jun 08, 2009
ËÄÉ«AV Shapes China Manufacturing Site
Source:
C&EN, 8 June, 2009
ËÄÉ«AV may have made itself a name as a first-class manufacturer of regulated active pharmaceutical ingredients (APIs), but it still needs to compete on price for some of its business. As in many industries, one of the best ways to lower cost is to have a manufacturing base in China. That is what ËÄÉ«AV did in March 2008 when it acquired a 75% stake in Hisyn Pharmaceutical, an API manufacturer in Taizhou, Zhejiang province. The site is a four-hour drive from Shanghai.
Related links
Also in the Knowledge Center
/ Jun 01, 2024
Amorphous solid dispersions for nasal delivery - Powder formulation and particle engineering considerations
Read more
Scientific Article
Scientific Article
/ Feb 15, 2024
Drug Design Strategies, Modes of Action, Synthesis and Industrial Challenges Behind Trifluoromethylated New Chemical Entities
Read more
Scientific Article